Preparation and application of efficient cell inactivation vaccine against new duck reovirus disease
A technology for reovirus disease and inactivated vaccine, which is applied in the field of high-efficiency cell inactivated vaccine for new duck reovirus disease to achieve a highly practical effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0024] In this example, the duck reovirus NDRV-TH11 strain was used to inoculate the monolayer of duck embryo fibroblasts immortalized in our laboratory, and the cytotoxicity was harvested when the cytopathy reached 80%; After the ester (BPL) is inactivated, it is mixed with a self-made nano adjuvant in an appropriate proportion to make a high-efficiency cell inactivated vaccine for new duck reovirus disease, and then the above inactivated vaccine is used to prevent new duck reovirus disease; breeding duck immunization and neutralizing antibody: take the inactivated vaccine to immunize breeding ducks once, 10ml / feather; 4 weeks later booster immunization once, 10ml / feather. The duck reovirus NDRV-TH11 strain is preserved in the China General Microbiological Culture Collection Center (CGMCC for short), and the depository unit is CGMCC. The address is at No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, China. The deposit date was November 28, 2013. The deposit n...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com